title: Management of post-traumatic nightmares: a review of pharmacologic and nonpharmacologic treatments since 2010.
abstract: Nightmares are a universal and timeless phenomenon. They occur in most healthy adults as well as a significant portion of clinical populations, especially those exposed to trauma. Considerable advances in the pharmacological and psychological treatment of post-traumatic nightmares have occurred over the last decade with continuing advances in psychological interventions over the last few years. Pharmacologically, the medication prazosin is showing robust clinical effects with minimal side effects. Psychologically, imagery rehearsal therapy commands the greater portion of the nightmare literature due to its established efficacy. These issues are reviewed in the following paper along with recommendations for future studies.
authors.affiliation: Trauma, Risk, and Resiliency Postdoctoral Fellowship Warrior Resiliency Program, San Antonio Military Medical Center, U.S. Army Southern Regional Medical Command, 7800 IH-10 West Suite 300, San Antonio, TX 78230, USA. Monica.Escamilla@amedd.army.mil
authors.forename: Monica
authors.initials: M
authors.lastname: Escamilla
authors.forename: Mercedes
authors.initials: M
authors.lastname: LaVoy
authors.forename: Bret A
authors.initials: BA
authors.lastname: Moore
authors.forename: Barry
authors.initials: B
authors.lastname: Krakow
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D004325:Dreams; D006801:Humans; D011613:Psychotherapy / Q000379:methods*; D012893:Sleep Wake Disorders / Q000628:therapy*; D013313:Stress Disorders, Post-Traumatic / Q000628:therapy*
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D000928:Antidepressive Agents; D014150:Antipsychotic Agents